# MultiOmics - cfDNA & evProtein

## 1. ctDNA/cfDNA

* **cfDNA - mbDNA (**Microbiome of cfDNA)
  * **✨ **_**2020 Nature**_ - Microbiome analyses of blood and tissues suggest cancer diagnostic approach 
* **cfDNA - Fragment-Size**
  * **✨ **_**2019 Nature**_ - Genome-wide cell-free DNA fragmentation in patients with cancer
* **ctDNA - Mutations+** 
  * **2020** _**Nature Med**_. - Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
  * _**2020 Nature**_ - Integrating genomic features for noninvasive early lung cancer detection
  * _**2019 Nature Medicine**_ - Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
  * **Papadopoulos N Lab**
    * _**2020 Science -**_ **ctDNA+PET-CT -** Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
    * **✨**_** 2018 Science -**_ **ctDNA+Protein(CancerSEEK)** - Detection and localization of surgically resectable cancers with a multi-analyte blood test

> [PDFs](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=%2FcfDNA\&mode=list) of ctDNA/cfDNA papers

## **2. cfDNA Methylation**

* **✨  **\[BS] **2021** _**Nature Biomedical Engineering**_ - Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning
* **✨ **\[Targeted BS] _**2021 Annals of Oncology**_ - **Grail and CCGA Consortium **- Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
* **✨ **\[Targeted BS] _**2020 Annals of Oncology**_ - **Grail and CCGA Consortium -** Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
* **✨ **\[meDIP] **2020** _**Nat Medicine**_ - Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
* _**2020 Nature Medicine**_ - Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
* _**2020 Sci Adv**_ - Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma. 
* _**2019 Clin Chem**_ - Detection of Colorectal Cancer in Circulating Cell-Free DNA by Methylated CpG Tandem Amplification and Sequencing
* _**2019 Blood Adv**_ - Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma
* _**2019 Gut**_ - Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma
* \[meDIP] _**2018 Nature**_ - Sensitive tumour detection and classification using plasma cell-free DNA methylomes
* \[chips] _**2018 Nature**_ - DNA methylation-based classification of central nervous system tumours
* \[WGBS] _**2017 Nature Genetics**_ -  Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA
* _**2017 Genomic Medicine**_ - Empirical comparison of reduced representation bisulfite sequencing and Infinium BeadChip reproducibility and coverage of DNA methylation in humans.
* _**2017 Cell Res**_ - 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers
* _**2015 Cell Res**_ - Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients 
* _**2014 Clin Epigenetics**_ - Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma.

> * [PDFs ](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=%2FcfDNA%2FcfDNA%20Methylation\&mode=list)of cfDNA Methylation papers

## 3. EV Proteomics

* **✨ **\[MS-EVP] _**2020 Cell**_ - Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
* \[APPA] _**2020 Sci Adv** -_ Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and response

> * [PDFs](https://cloud.tsinghua.edu.cn/d/f72ee6992a1e4ec78044/?p=%2FProteomics\&mode=list) of proteomics
